Literature DB >> 23731464

The suppressive effect of IL-27 on encephalitogenic Th17 cells induced by multiwalled carbon nanotubes reduces the severity of experimental autoimmune encephalomyelitis.

Adriel S Moraes1, Rosemeire F O Paula, Fernando Pradella, Mariana P A Santos, Elaine C Oliveira, Felipe von Glehn, Daniela S Camilo, Helder Ceragioli, Alfredo Peterlevitz, Vitor Baranauskas, Walkyria Volpini, Alessandro S Farias, Leonilda M B Santos.   

Abstract

BACKGROUND: Both Th1 and Th17 cells specific for neuroantigen are described as encephalitogenic in the experimental autoimmune encephalomyelitis (EAE) model. AIM: The proposal of this study was to investigate how carbon nanotubes internalized by antigen-presenting cells (APCs) affect the development of encephalitogenic CD4(+) T cells.
METHODS: Therefore, we stimulated encephalitogenic T cells in the presence or not of multiwalled carbon nanotube (MWCNT). After the incubation, we analyzed the expression profile of the encephalitogenic T cells and their capacity to induce EAE.
RESULTS: Encephalitogenic CD4(+) T cells cultured with APCs that were previously incubated with MWCNTs do not express IL-17. The adoptive transfer of these cells causes less severe EAE than the transfer of both Th1 and Th17 cells that are not incubated with MWCNTs. These results suggest that the increased IL-27 level produced by the APCs incubated with the carbon nanotubes inhibits the development of Th17 cells. This observation is confirmed by the concomitant reduction in the level of RORγt, which is a transcription factor essential for the development of Th17 cells. Moreover, the incubation of encephalitogenic T cells devoid of Th17 cells with neutralizing anti-IL-27 antibodies restored the production of IL-17.
CONCLUSION: This finding confirms the suppressive effect of IL-27 on encephalitogenic Th17 cells. The results presented suggest that the stimulation of APCs with carbon nanoparticles prior to neuroantigen presentation affects the development of the Th17 subset of encephalitogenic CD4(+) T lymphocytes and results in less severe EAE.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  Antigen presentation; Autoimmunity; Demyelination; Multiwalled carbon nanotube

Mesh:

Substances:

Year:  2013        PMID: 23731464      PMCID: PMC6493452          DOI: 10.1111/cns.12121

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  9 in total

1.  Activating α7 nicotinic acetylcholine receptor inhibits NLRP3 inflammasome through regulation of β-arrestin-1.

Authors:  Ping Ke; Bo-Zong Shao; Zhe-Qi Xu; Xiong-Wen Chen; Wei Wei; Chong Liu
Journal:  CNS Neurosci Ther       Date:  2017-09-21       Impact factor: 5.243

2.  Comparative analysis of lung and blood transcriptomes in mice exposed to multi-walled carbon nanotubes.

Authors:  Timur O Khaliullin; Naveena Yanamala; Mackenzie S Newman; Elena R Kisin; Liliya M Fatkhutdinova; Anna A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2020-01-22       Impact factor: 4.219

3.  Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome.

Authors:  Bo-Zong Shao; Wei Wei; Ping Ke; Zhe-Qi Xu; Jv-Xiang Zhou; Chong Liu
Journal:  CNS Neurosci Ther       Date:  2014-12       Impact factor: 5.243

4.  Designing inorganic nanomaterials for vaccines and immunotherapies.

Authors:  Krystina L Hess; Igor L Medintz; Christopher M Jewell
Journal:  Nano Today       Date:  2019-05-29       Impact factor: 20.722

Review 5.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

Review 6.  Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.

Authors:  Yue Lang; Fengna Chu; Donghui Shen; Weiguanliu Zhang; Chao Zheng; Jie Zhu; Li Cui
Journal:  Mediators Inflamm       Date:  2018-04-17       Impact factor: 4.711

Review 7.  Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines.

Authors:  Romina Mitarotonda; Exequiel Giorgi; Tatiane Eufrasio-da-Silva; Alireza Dolatshahi-Pirouz; Yogendra Kumar Mishra; Ali Khademhosseini; Martin F Desimone; Mauricio De Marzi; Gorka Orive
Journal:  Biomater Adv       Date:  2022-04-22

Review 8.  Immunomodulation, Toxicity, and Therapeutic Potential of Nanoparticles.

Authors:  Ashutosh Pandey; Abhinava K Mishra
Journal:  BioTech (Basel)       Date:  2022-09-09

Review 9.  The regulatory mechanism and potential application of IL-23 in autoimmune diseases.

Authors:  De-Kai Xiong; Xiang Shi; Miao-Miao Han; Xing-Min Zhang; Na-Na Wu; Xiu-Yue Sheng; Ji-Nian Wang
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.